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Abstract
After reading this article, the learner should be able to: • Describe the importance of dosage
administration aids as a way to help improve medication compliance and therapeutic outcomes, as well
as averting potential adverse drug events; • Identify the benefits of good communication between
pharmacists, prescribing doctors and, when appropriate, hospital and/or aged care facility staff for the
timely packaging, dispensing and administration of the correct medications in dosage administration
aids.
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education
dosage administration aids

Blister-packed medications:

improving compliance and reducing adverse events
Dr Judy R Mullan PhD, SHPA Fellow, BPharm, BA, senior lecturer, Graduate School of Medicine, University of Wollongong. John C Mullan BPharm, LLB, pharmacist

BY ADVOCATING THE USE OF DOSE
ADMINISTRATION AIDS AND THROUGH
THEIR PROFESSIONAL CARE AND SERVICES,
PHARMACISTS ARE WELL PLACED TO HELP
IMPROVE PATIENT MEDICATION COMPLIANCE
AMONG OLDER AUSTRALIANS.
Background
People aged 65 years and older
make up more than 13% (approx 2.7
million) of the Australian population.1
Furthermore, 25% of this older cohort
take an average of 4.5 medications
concurrently.2 Despite the fact that
failing to follow recommended
medication regimens results in poor
health outcomes,3 between 40% and
60% of older people are not taking
their medications as prescribed.4
According to the Australian Bureau of
Statistics (ABS) in 2006, more than 90%
older Australians suffered from one or
several (acute or chronic) illnesses for
which they took different medications
concurrently.5
In Australia, 6% of the people aged
65 years and older and more than 26%
of those aged 85 years and older live
in non-private dwellings, hostels and
residential aged care facilities (RACFs).2
Importantly, just over 40% of the care
facility residents have been diagnosed
with some level of capacity impairment
such as impaired cognitive states,
Alzheimer’s disease or some form
of dementia6 and are prescribed an
average of seven medications daily.7,8
It is estimated that an individual’s
inability to manage their medications

After reading this article, the
learner should be able to:
• Describe the importance of
dosage administration aids as a
way to help improve medication
compliance and therapeutic
outcomes, as well as averting
potential adverse drug events;
• Identify the benefits of good
communication between
pharmacists, prescribing
doctors and, when appropriate,
hospital and/or aged care facility
staff for the timely packaging,
dispensing and administration
of the correct medications in
dosage administration aids.
Competencies addressed:
2.1.3, 3.1.4, 3.1.5, 3.2.2, 3.2.3, 7.3.2

accounts for 23% of admissions into
residential aged care facilities.4
The use of dose administration
aids (DAAs) can be used to improve
medication compliance, especially
among people with age related
cognitive and physical impairments
and poor health literacy skills.4,9
Pharmacists, by advocating the
use of DAAs and through their
increased professional care and
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services, are well placed to help
improve patient compliance, thus
affording older people the luxury of
remaining domiciled in their own
homes and reducing the demand
for RACF placements based on poor
medication management.
Currently the Department of
Health and Ageing and the Pharmacy
Guild of Australia are staging the DAA
Program to develop the broader use of
government-sponsored DAA services
within the community. The Quality
Care Pharmacy Program (QCPP) offers
a system of voluntary accreditation
of pharmacies that comply with
professional standards including
comprehensive DAAs guidelines and
standards, dispensing standards and
counselling standards. It is timely
therefore that pharmacists recognise,
understand and make contingencies
to mitigate against the many factors
that negatively affect drug compliance
in older people. As the community
ages and as DAAs become more
prevalent pharmacists roles will
change, with greater time and
attention being required in educating
patients/carers, communicating with
other healthcare professionals and
acting as patient advocates when non
compliance is an issue or to avoid
adverse drug events (ADEs).
With this background, the ‘Blister
Packed Medication use Amongst
Pharmacies in the Illawarra Region’
study was undertaken. The aims and
objectives of the study were as follows:
1. to gain an understanding of the
extent to which blister-packed
medications are used in the Illawarra;
2. to investigate the efficiency of DAAs;

3. to investigate the reasons why DAAs
are supplied in the Illawarra.

Methodology
Following ethics approval from the
University of Wollongong Human
Ethics Committee, a written survey was
sent by mail and/or in person to the 55
licensed Illawarra-based community
pharmacies between December 2007
and February 2008. The surveys were
completed on a voluntary basis by
community pharmacy personnel and
sent back to the researchers.
Quantitative data from the survey
was analysed using descriptive
statistical analysis, while qualitative
data was thematically analysed. The
survey tool used for data collection
purposes had been specifically
developed for this study and had
not been previously validated. Some
questions within the tool, however,
had been derived from the Dose
Administration Aids (DAA) Program
registration form (2008), while other
questions related to information
about the numbers of patients
receiving blister packs, the number of
medications per blister pack and the
impact of the provision of blister pack
services on pharmacy workloads.
results
Forty one of the 55 pharmacies (74.5%)
completed the survey questionnaire
and responded that during the time of
the study they packaged medication
blister packs or DAAs for 2,549 Illawarra
residents, 2,261 (88.7%) of whom
were aged 65 years and older. The
pharmacists suggested that that the
most common reason for being asked
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to provide a DAA was because of the
patient’s complex medication regimen,
followed by patient forgetfulness
and/or cognitive impairments such
as dementia/Alzheimer’s disease.
Importantly, the pharmacists stated
that in the majority of cases they had
initially recommended the use of the
DAA to either the patient and/or their
carer or alternatively the patient’s
general practitioner had done so.
Based on the survey questions
regarding the return of the DAAs
(ie. blister packs returned to the
pharmacy for repackaging), 77.7% of
the pharmacy respondents said that
blister packs were returned having
been used correctly (> 75% of the
medications had been removed
correctly), 16.49% somewhat
correctly (25–75% of medications
removed), and 5.94% had not been
used correctly (< 25% 0f medications
removed). The survey respondents
also suggested that an overwhelming
98.6% of DAAs returned for residents
of RACFs had been used correctly.
Just over 50% of the pharmacy
respondents suggested that
communications about medication
changes (eg. warfarin doses) requiring
repackaging, between themselves and
GPs was ‘good’; 25% of them rated
this communication exchange as
‘average’; and a further 25% suggested
that it was ‘below average’. Similarly,
communication about medication
changes between pharmacies and the
22 RACFs provided with DAAs was
deemed to be ‘good’ for 45.5% of the
respondents, ‘average’ for 36.4% and
‘below average’ for 19.6%.
The efficiency of their individual
pharmacy processes for dealing with
these recommended medication
changes were also rated by
respondents, with 22.5% rating them
as ‘excellent’, 57.5% rating them
as ‘good’, and 20% rating them as
‘average’ or ‘below average’.
Finally, respondents were asked to
rate the impact of changes to blister
pack medications on the workload

of the pharmacy staff. Some 48.6%
of respondents rated the impact as
between ‘very heavy’ and ‘heavy’, while
the remaining 51.4% rated changes
as only having a ‘moderate’ to ‘slight
impact’ on their workload.
Some of the other findings of the
study included comments about
the efficiency of the DAA packaging
and dispensing being heavily
reliant on good communication
between the pharmacist and the GP.
Respondents also commented on
poor communication from hospitals
to GPs and pharmacists about changes
to medications regimens which are
made for patients discharged from
hospital. This poor communication
they felt impeded the correct and
timely packaging, dispensing and
administration of post-discharge
medications in DAAs.
Discussion
Evidence suggests that poor
medication compliance, especially
among older people suffering from
co-morbidities and taking several
different medications (polypharmacy),
increases the likelihood of ADEs.10,11
Good medication compliance is one
of the key strategies that can be used
to improve therapeutic outcomes
and reduce the incidence of ADEs.12,13
This study suggests that medication
compliance can be improved by
providing DAAs for patients generally,
but in particular older patients with
complex medication regimens and
cognitive and/or physical decline, living
in both community and residential
aged care settings.
Good communication between the
pharmacies providing the DAAs, the
prescribing doctors and the residential
aged care facility (for aged care
residents) is a very important factor to
facilitate timely packaging, dispensing
and administration of the correct
medications within a DAA. The hiatus
in communication between hospital
and community pharmacies regarding
discharge patients’ medications was of

concern to the pharmacists surveyed
in the study. Their apprehensions
represented a heightened perception
of risk in dispensing errors, adverse
drug reactions, and incorrect
counselling of patients. A more
streamlined, accurate and standard
system of communication should
therefore be installed to ensure
the continuity of patient care after
discharge from hospital.
It is noteworthy that despite the
imperfections of the current systems,
despite the impost of blister pack
changes on pharmacists’ workloads
and despite the poor remuneration of
pharmacists for the blister pack service,
pharmacists are still willing to support
and provide DAAs because they believe
it is a worthwhile community service.
The Illawarra study found that
approximately only 6% (2,261) of
the almost 37,000 Illawarra residents
aged 60 years and older were
being provided with a DAA from an
Illawarra-based pharmacy. It should
be acknowledged that some patients
could have been provided with a
DAA from a pharmacy outside of the
region, and others would not have
required a DAA.
It appears however, that the
service is being grossly underutilised,
especially considering the benefits
that can be derived from such a
service for ‘at risk’ patients with
complex medications regimens
and/or suffering from cognitive
and/or physical impairments. One
respondent suggested an awareness
campaign to endorse and inform the
public of the benefits of DAAs should
be undertaken.
The Illawarra study, although
limited in its scope, shows that there
is undoubtedly a case for collective
professional improvement of
pharmacy practice in respect of DAAs
with a view to improving patient
compliance and reducing ADEs. Dylan
was right, ‘For the times they are a
changing’, and the profession must
take heed.

conclusion
The Illawarra study is a snapshot of
DAA usage which will continue to
increase into the near future and
provide considerable benefit to
the community particularly with
regard to increasing compliance
rates, reducing ADEs and keeping
people domiciled in their own homes
for longer or for life. To that end
pharmacists will continue to increase
their professional role as educators
and communicators, facilitating the
medication management process and
advocating on behalf of patients.
Pharmacists are no longer simply
dispensers or sellers of medicines.
Hopefully in the not-too-distant
future pharmacists will be recognised
and remunerated justly for the
professional role they play.
Recommendations based on the
study include: the investigation
and standardisation of discharge
procedures with emphasis on the
continuity of care; the introduction
of a nation-wide database to
limit adverse outcomes due to
polypharmacy and the continued
education of all medical personnel
involved in the continuity of
patient care.
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